Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation

Genes and Development

Volumn 13, Issue 9, 1999, Pages 1181-1189

  Montagnoli, Alessia ^a,b   Fiore, Francesca ^b   Eytan, Esther ^c   Carrano, Andrea C ^a   Draetta, Giulio F ^b   Hershko, Avram ^c   Pagano, Michele ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Cdk; Cell cycle; Cki; p27; Tumor suppressor; Ubiquitination

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PROTEASOME; PROTEIN P27; UBIQUITIN;

ARTICLE; CELL CYCLE; COMPLEX FORMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TRANSCRIPTION REGULATION;

EID: 0033135878     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: 10.1101/gad.13.9.1181     Document Type: Article

References (43)

1. Alessandrini, A., D.S. Chiaur, and M. Pagano. 1997. Regulation of the cyclin-dependent kinase inhibitor p27 by degradation and phosphorylation. Leukemia 11: 342-345.
2. Amon, A., S. Imiger, and K. Nasmyth. 1994. Closing the cell cycle circle in yeast: G2 cyclin proteolysis initiated at mitosis persists until the activation of G1 cyclins in the next cycle. Cell 77: 1037-1050.
3. Kip1 with cyclin A/Cdk2 and cyclin D2/Cdk4. J. Biol. Chem. 272: 25863-25872.
4. Brancolini, C., D. Lazarevic, J. Rodriguez, and C. Schneider. 1997. Dismantling cell-cell contacts during apoptosis is coupled to a caspase-dependent proteolytic cleavage of betacatenin. J. Cell. Biol. 139: 759-771.
5. Brandeis, M. and T. Hunt. 1996. The proteolysis of mitotic cyclins in mammalian cells persists from the end of mitosis until the onset of S phase. EMBO J. 15: 5280-5289.
6. Cdc2 protein kinase. EMBO J. 6: 3507-3514.
7. Carlson, B.A., M.M. Dubay, E.A. Sausville, L. Brizuela, and P.J. Worland. 1996. Flavopiridol induces G1 arrest with inhibition of cyclin-dependent kinase (CDK) 2 and CDK4 in human breast carcinoma cells. Cancer Res. 56: 2973-2978.
8. Cheng, M., V. Sexl, C.J. Sherr, and M.F. Roussel. 1998. Assembly of cyclin D-dependent kinase and titration of p27Kipl regulated by mitogen-activated protein kinase kinase (MEK1). Proc. Natl. Acad. Sci. 95: 1091-1096.
9. Choi, Y.H., S.J. Lee, P. Nguyen, J.S. Jang, J. Lee, M.L. Wu, E. Takano, M. Maki, P.A. Henkart, and J.B. Trepel. 1997. Regulation of cyclin D1 by calpain protease. J. Biol. Chem. 272: 28479-28484.
10. Cuervo, A.M., W. Hu, B. Lim, and J.F. Dice. 1998. IkappaB is a substrate for a selective pathway of lysosomal proteolysis. Mol. Biol. Cell. 9: 1995-2010.
11. Desai, D., Y. Gu, and D. Morgan. 1992. Activation of human cyclin-dependent kinase in vitro. Mol. Biol. Cell 3: 571-582.
12. Hannon, G.J. 1995. Expression of cell cycle proteins using recombinant baculoviruses. In Cell cycle: Materials and methods (ed. M. Pagano) pp. 231-243. Springer-Verlag, New York, NY.
13. Kip1 accumulation during the cell cycle. Science 271: 1861-1864.
14. Hershko, A. and H. Heller. 1985. Occurrence of a polyubiquitin structure in ubiquitin-protein conjugates. Biochem. Biophys. Res. Commun. 128: 1079-1086.
15. Hershko, A. and I. A. Rose. 1987. Ubiquitin-aldehyde: A general inhibitor of ubiquitin-recycling processes. Proc. Natl. Acad. Sci. 84: 1829-1833.
16. Katayose, Y., M. Kim, A.N. Rakkar, Z. Li, K.H. Cowan, and P. Seth. 1997. Promoting apoptosis: A novel activity associated with the cyclin-dependent kinase inhibitor p27. Cancer Res. 57: 5441-5445.
17. Kubbutat, M.H. and K.H. Vousden. 1998. Keeping an old friend under control: Regulation of p53 stability. Mol. Med. Today 4: 250-256.
18. Latres, E., D.S. Chiaur, and M. Pagano. 1999. The human F-box protein β-Trcp associates with the Cull/Skpl complex and regulates the stability of β-catenin. Oncogene 18: 849-854.
19. Kip1 mediates apoptosis in endothelial cells through activation of Cdk2: Role of a caspase cascade. Mol. Cell 1: 553-563.
20. Loda, M., B. Cukor, S. Tam, P. Lavin, M. Fiorentino, G. Draetta, J. Jessup, and M. Pagano. 1997. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med. 3: 231-234.
21. Meijer, L. 1995. Chemical inhibitors of cyclin-dependent kinases. Prog. Cell Cycle Res. 1: 351-363.
22. Millard, S., J. Yan, H. Nguyen, M. Pagano, H. Kiyokawa, and A. Koff. 1997. Enhanced ribosomal association of p27 mRNA is a mechanism contributing to accumulation during growth arrest. J. Biol. Chem. 272: 7093-7098.
23. Muller, D., C. Bouchard, B. Rudolph, P. Steiner, I. Stuckmann, R. Saffrich, W. Ansorge, W. Huttner, and M. Eilers. 1997. Cdk2-dependent phosphorylation of p27 facilitates its Mycinduced release from cyclin E/cdk2 complexes. Oncogene 15: 2561-2576.
24. Kip1, a G1 cyclin-dependent kinase inhibitor, is dependent on CDK2 activity and the proteasome. Mol. Cell Biol. 19: 1190-1201.
25. O'Connor, P. and J. Jackman. 1995. Synchronization of mammalian cells. In Cell cycle: Materials and methods (ed. M. Pagano), pp. 63-74. Springer-Verlag, New York, NY.
26. Ohtsubo, M., A. Theodoras, J. Schumacher, J.M. Roberts, and M. Pagano. 1995. Human cyclin E, a nuclear protein essential for the G1 to S phase transition. Mol. Cell Biol. 15: 2612-2124.
27. Pagano, M. 1997. Regulation of cell cycle regulatory proteins by the ubiquitin pathway. FASEB J. 11: 1067-1075.
28. Pagano, M., R. Pepperkok, F. Verde, W. Ansorge, and G. Draetta. 1992. Cyclin A is required at two points in the human cell cycle. EMBO J. 11: 761-771.
29. Pagano, M., R. Pepperkok, J. Lukas, V. Baldin, W. Ansorge, J. Bartek, and G. Draetta. 1993. Regulation of the human cell cycle by the Cdk2 protein kinase. J. Cell Biol. 121: 101-111.
30. Pagano, M., S. Tam, A. Theodoras, P. Beer, G. Delsal, V. Chau, R. Yew, G. Draetta, and M. Rolfe. 1995. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 269: 682-685.
31. Patton, E., A. Willems, and M. Tyers. 1998. Combinatorial control in ubiquitin-dependent proteolysis: Don't Skp the F-box hypothesis. Trends Genet. 14: 6-14.
32. Pickart, C.M. 1997. Targeting of substrates to the 26S proteasome. FASEB J. 11: 1055-1066.
33. Pines, J. 1998. Regulation of the G2 to M transition. In Cell cycle control (ed. M. Pagano), pp. 57-78. Springer-Verlag, New York, NY.
34. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 79: 59-66.
35. Russo, A.A., P.D. Jeffrey, A.K. Patten, J. Massague, and N.P. Pavletich. 1996. Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A/Cdk2 complex. Nature 382: 325-331.
36. Sheaff, R.J. and J.M. Roberts. 1998. Regulation of G1 phase. In Cell cycle control (ed. M. Pagano), pp. 1-34. Springer-Verlag, New York, NY.
37. Kip1. Genes & Dev. 11: 1464-1478.
38. Tam, S., A. Theodoras, J.W. Shay, G.F. Draetta, and M. Pagano. 1994. Differential expression and regulation of Cyclin D1 protein in normal and tumor human cells: Association with Cdk4 is required for Cyclin D1 function in G1 progression. Oncogene 9: 2663-2674.
39. Toyoshima, H. and T. Hunter. 1994. p27, a novel inhibitor of G1-cyclin-cdk protein kinase activity, is related to p21. Cell 78: 67-74.
40. van den Heuvel, S. and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262: 2050-2054.
41. Kip1. EMBO J. 16: 5334-5344.
42. β-TRCP ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IκBα and β-catenin and stimulates IκBβ ubiquitination in vitro. Genes & Dev. 13: 270-283.
43. Yaron, A., H. Gonen, I. Alkalay, A. Hatzubai, S. Jung, S. Beyth, F. Mercurio, A.M. Manning, A. Ciechanover, and N.Y. Ben. 1997. Inhibition of NFκB cellular function via specific targeting of the IκB-ubiquitin ligase. EMBO J. 16: 6486-6494.